Detailed price information for Compass Pathways Plc ADR (CMPS-Q) from The Globe and Mail including charting and trades.

The ATAI deal is a clear signal Lilly will fund and scale psychedelic mental-health assets, not just dabble. LLY’s cash ...

Shares of AtaiBeckley soared as much as 50% in premarket trading on Thursday after a report said Eli Lilly is in advanced talks to acquire the psychedelic drug developer in a deal that could be ...

We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. COMPASS Pathways plc (NASDAQ:CMPS) ...

(NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an ...

Summary: As the ancient adage goes, ‘a journey of a thousand miles begins with a single step’ — and India’s bold stride into ...

The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive ...

As the psychedelic drug industry shifts from a speculative niche to a potential part of mainstream healthcare, investors have ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards ...

An in-depth look at the leading psychedelic stocks in the U.S. stock market this year. Here's what you need to know.

Cathie Wood's ARK added to its Meta Platforms (NASDAQ:META) position while further reducing its stake in Advanced Micro Devices (NASDAQ:AMD), according to the firm's daily trade disclosure released ...

At its core, Tabu is redefining how the world perceives her unconventional life and career by shifting the narrative from ...